Schedule 13G ownership disclosure
Akers Biosciences Inc
Security class unavailable · CUSIP: 00973E102
Event date: 2019-12-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-025855
- Form type
- SC 13G
- Filer
- ALPHA CAPITAL ANSTALT
- CIK
- CIK 1140358
- Filed
- Dec 11, 2019
- Reporting period
- Dec 09, 2019
- Description
- Schedule 13G beneficial ownership